Body Weight Changes in Hyperthyroidism: Timing and Possible Explanations During a One Year Repeated Measurement Study

Overview

Journal Eur Thyroid J

Specialties Endocrinology
Oncology

Date 2021 Jun 28

PMID 34178706

Citations 1

Authors

Jesper Karmisholt

Allan Carle

Stig Andersen

Affiliations

Soon will be listed here.

Abstract

Background: Weight gain during treatment of hyperthyroidism is a frequent and for many patients unwanted outcome. With this repeated measurement study, we explored the timing of weight changes during the first year of antithyroid drug (ATD) treatment and assessed the correlation between body weight changes and changes in thyroid hormones, resting energy expenditure (REE), physical activity level, and energy efficiency.

Methods: Patients with new onset hyperthyroidism were investigated every second month during the first year of ATD treatment. At each investigation, the following were measured: body weight, thyroid hormone concentrations, physical activity level, and daily number of steps, REE, and exercise performance.

Results: Two men and eleven women, all sedentary, mean age 49(SD: 9.3) years were included. Significant changes after 1 year occurred for body weight (68.9-74.1 kg), thyroid hormones (free T3 [fT3] 17.5 to 4.42 pmol/L), REE (1,630-1,484 kcal/24 h), and energy efficiency at lower (50 W) workloads (16.0-17.6%). In individual patients, only REE and fT3 correlated to changes in body weight. Physical activity level did not change during treatment.

Conclusion: In this study, treatment of hyperthyroidism was associated with marked increase in body weight in the patients. This increase correlated to a decrease in REE and only to a negligible extent to changes in energy efficiency and not at all to changes in physical activity level of daily living.

Citing Articles

Inflammasome activation as a link between obesity and thyroid disorders: Implications for an integrated clinical management.

Le Moli R, Vella V, Tumino D, Piticchio T, Naselli A, Belfiore A Front Endocrinol (Lausanne). 2022; 13:959276.

PMID: 36060941 PMC: 9437482. DOI: 10.3389/fendo.2022.959276.

References

Kyriacou A, Kyriacou A, Makris K, Syed A, Perros P . Weight gain following treatment of hyperthyroidism-A forgotten tale. Clin Obes. 2019; 9(5):e12328. DOI: 10.1111/cob.12328. View

Kimura H, Kawagoe Y, Kaneko N, Fessler H, Hosoda S . Low efficiency of oxygen utilization during exercise in hyperthyroidism. Chest. 1996; 110(5):1264-70. DOI: 10.1378/chest.110.5.1264. View

Kung A . Neuromuscular complications of thyrotoxicosis. Clin Endocrinol (Oxf). 2007; 67(5):645-50. DOI: 10.1111/j.1365-2265.2007.02909.x. View

Ainsworth B, Haskell W, Leon A, Jacobs Jr D, Montoye H, Sallis J . Compendium of physical activities: classification of energy costs of human physical activities. Med Sci Sports Exerc. 1993; 25(1):71-80. DOI: 10.1249/00005768-199301000-00011. View

Irace L, Pergola V, Di Salvo G, Perna B, Tedesco M, Ricci C . Work capacity and oxygen uptake abnormalities in hyperthyroidism. Minerva Cardioangiol. 2006; 54(3):355-62. View

Borg G . Psychophysical bases of perceived exertion. Med Sci Sports Exerc. 1982; 14(5):377-81. View

Sietsema K, Wasserman K . O2 uptake in hyperthyroidism during constant work rate and incremental exercise. Eur J Appl Physiol Occup Physiol. 1991; 62(4):261-7. DOI: 10.1007/BF00571550. View

Lonn L, Stenlof K, Ottosson M, Lindroos A, Nystrom E, Sjostrom L . Body weight and body composition changes after treatment of hyperthyroidism. J Clin Endocrinol Metab. 1998; 83(12):4269-73. DOI: 10.1210/jcem.83.12.5338. View

Bland J, Altman D . Calculating correlation coefficients with repeated observations: Part 1--Correlation within subjects. BMJ. 1995; 310(6977):446. PMC: 2548822. DOI: 10.1136/bmj.310.6977.446. View

10.

Harris J, Benedict F . A Biometric Study of Human Basal Metabolism. Proc Natl Acad Sci U S A. 1918; 4(12):370-3. PMC: 1091498. DOI: 10.1073/pnas.4.12.370. View

11.

Bland J, Altman D . Calculating correlation coefficients with repeated observations: Part 2--Correlation between subjects. BMJ. 1995; 310(6980):633. PMC: 2549010. DOI: 10.1136/bmj.310.6980.633. View

12.

Simonides W, van Hardeveld C . Thyroid hormone as a determinant of metabolic and contractile phenotype of skeletal muscle. Thyroid. 2008; 18(2):205-16. DOI: 10.1089/thy.2007.0256. View

13.

De Leo S, Lee S, Braverman L . Hyperthyroidism. Lancet. 2016; 388(10047):906-918. PMC: 5014602. DOI: 10.1016/S0140-6736(16)00278-6. View

14.

Brennan M, Powell C, Kaufman K, Sun P, Bahn R, Nair K . The impact of overt and subclinical hyperthyroidism on skeletal muscle. Thyroid. 2006; 16(4):375-80. DOI: 10.1089/thy.2006.16.375. View

15.

Jacobsen R, Lundsgaard C, Lorenzen J, Toubro S, Perrild H, Krog-Mikkelsen I . Subnormal energy expenditure: a putative causal factor in the weight gain induced by treatment of hyperthyroidism. Diabetes Obes Metab. 2006; 8(2):220-7. DOI: 10.1111/j.1463-1326.2005.00486.x. View

16.

Silva J . The thermogenic effect of thyroid hormone and its clinical implications. Ann Intern Med. 2003; 139(3):205-13. View

17.

Levine J, Nygren J, Short K, Nair K . Effect of hyperthyroidism on spontaneous physical activity and energy expenditure in rats. J Appl Physiol (1985). 2002; 94(1):165-70. DOI: 10.1152/japplphysiol.00499.2002. View

18.

Harris E, Cooil B, Shakarji G, Williams G . On the use of statistical models of within-person variation in long-term studies of healthy individuals. Clin Chem. 1980; 26(3):383-91. View

19.

Chng C, Lim A, Tan H, Kovalik J, Tham K, Bee Y . Physiological and Metabolic Changes During the Transition from Hyperthyroidism to Euthyroidism in Graves' Disease. Thyroid. 2016; 26(10):1422-1430. DOI: 10.1089/thy.2015.0602. View

20.

Aadahl M, Jorgensen T . Validation of a new self-report instrument for measuring physical activity. Med Sci Sports Exerc. 2003; 35(7):1196-202. DOI: 10.1249/01.MSS.0000074446.02192.14. View